XBI (XBI) Stock Price & Analysis
XBI (XBI) rose 2.30% to USD 131.38 as of June 10, 2026 at 01:55 UTC, according to Nexqual real-time market data.
XBI last closed at USD 128.43; the session ranged USD 127.56–132.35 on volume of 11,526,471 shares. Market capitalization is —, with a 52-week range of USD 80.9–139.19 (PCX). Source: Nexqual, June 10, 2026 at 01:55 UTC.
Key Statistics (as of June 10, 2026 at 01:55 UTC)
| Price | USD 131.38 |
|---|---|
| Change | ▲ 2.30% (up) |
| Previous Close | USD 128.43 |
| Open | USD 131.13 |
| Day Range | USD 127.56 – 132.35 |
| 52-Week Range | USD 80.9 – 139.19 |
| Volume | 11,526,471 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (XBI)
Nexqual's technical model rates XBI "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 01:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.35 (neutral) |
| vs SMA50 | Below (USD 132.29) |
| MACD | -0.5 (negative) |
Financial Health Score (XBI)
Nexqual rates XBI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 01:55 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IBB | iShares Biotechnology ETF | USD 169.36 | ▲ 0.55% |
| XLV | State Street Health Care Select | USD 154.57 | ▲ 1.02% |
| XLI | State Street Industrial Select | USD 175.6 | ▲ 0.82% |
| XLK | State Street Technology Select | USD 180.77 | ▲ 0.26% |
| XLF | State Street Financial Select S | USD 52.46 | ▲ 0.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:55 UTC. This page is informational and not investment advice.